Alexion Paying $8.4 Billion to Acquire Synageva

07.05.2015 - US-based Alexion Pharmaceuticals is paying $8.4 billion to acquire compatriot rare disease specialist Synageva BioPharma. The deal expected to close in mid-2015 has raised...